MetaCap

ADMA Biologics Statistics

NASDAQ: ADMAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

13.17-0.17 (-1.27%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ADMA Biologics by the numbers

ADMA Biologics has a market capitalization of $2.92 billion based on 221.85M shares outstanding. Its trailing P/E ratio is 17.1, and its forward P/E is 14.1. The stock trades 20.0% above its 50-day average and 23.8% above its 200-day average.

Average daily trading volume is 3.23M shares, or about $42.6 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

ADMA valuation vs. peer median

ADMA compared with the median of 8 peer companies
MetricADMAPeer medianDifference
Market cap$2.92B$3.07B-5%
Forward P/E14.161.1-77%
Avg. volume3.23M1.89M+71%

Peer median across 8 companies: DNLI, VCEL, IOVA, RLAY, TARS, BEAM, CRSP, BCRX.

Valuation

Price / sales (latest FY)
5.73

Price and trading

Previous close
13.34
Open
13.26
Day range
13.13 – 13.47
52-week range
7.21 – 20.46
52-week change
-23.34%
Beta
—
Volume
2.45M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
2.92B
Pe
17.10
Forward Pe
14.06
Eps
0.77
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
20.46
Week52 Low
7.21
Avg Volume
3.23M
Shares Outstanding
221.85M
Ma50
10.97
Ma200
10.64
Earnings Date
Nov 4, 2026
Pct From52w High
-35.62%
Pct From52w Low
82.66%

Related